Exact Sciences (EXAS) Competitor Comparison
We are evaluating the key criteria listed to compare Exact Sciences (EXAS) against its competitors in the Diagnostics & Research industry.
Market Capitalization
16 / 58Gross Profits
14 / 52Total Revenue
16 / 57EBITDA
52 / 56Free Cashflow
27 / 56Quick Ratio
31 / 57Earnings per Share
37 / 56Dividend yield
0 / 9Total Cash
12 / 57Performance 3 years
28 / 58Performance 5 years
33 / 58Performance 10 years
22 / 58Linearity 3 years
23 / 58Linearity 5 years
16 / 58Linearity 10 years
18 / 58Total Rank
43 / 58Dividend Rank
49 / 58Valuation Rank
24 / 58Piotroski Rank
40 / 58Muliplier Rank
46 / 58Quick Ratio - EXAS ranking 31 / 57
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.